AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)

Clinical trial NCT02141672 · COMPLETED

Trial details

NCT number: NCT02141672
Sponsor: Aurinia Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2014-06-01
Primary completion: 2016-07-01
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.